Navigation Links
Discovery of new hormone opens doors to new type 2 diabetes treatments
Date:5/7/2013

d insulin production in the pancreas, resulting in too much glucose in the blood.

The majority of cases of type 2 diabetes are related to failure of insulin action in the body. However, for decades researchers and physicians have been faced with a conundrum: not all who are obese or resistant to insulin develop type 2 diabetes. In fact, many patients who are severely obese never develop the disease. As a result scientists have theorized that an unknown factor is involved in regulating glucose metabolism in the liver, and perhaps the presence or absence of this element might determine who gets the disease.

"It was surprising to find that a critical hormone playing a pathological role in diabetes turned out to be the secreted form of aP2, which for decades has been considered a protein that resides inside the fat cells," said Hotamisligil. In the new study, HSPH researchers first increased the levels of aP2 in normal, healthy mice to match the high blood aP2 levels seen in obese mice and humans. This resulted in impaired glucose metabolism. Next, they reduced the blood aP2 levels in obese and diabetic mice to low levels seen in lean healthy mice. This intervention restored glucose metabolism to its normal status. Therefore, the investigators reached the conclusion that the amount and action of aP2 in blood was critical for diabetes, opening up new avenues for potentially being able control or prevent type 2 diabetes. The researchers also identified a potential therapeutic role for a novel aP2 antibody that neutralizes aP2 activity and corrects type 2 diabetes in mice.

"The consequences of this discovery are profound, and the potential therapeutic applications by switching this protein off have the capability to reshape the way physicians treat diabetes," said lead author Haiming Cao, postdoctoral fellow in the Department of Genetics and Complex Diseases at HSPH.


'/>"/>

Contact: Marge Dwyer
mhdwyer@hsph.harvard.edu
617-432-8416
Harvard School of Public Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Discovery may help prevent chemotherapy-induced anemia
2. Discovery may help prevent HIV reservoirs from forming
3. An important discovery in breast cancer by IRCM researchers
4. Genetic discovery found to influence obesity in people of African ancestry
5. Accidental discovery may lead to improved polymers
6. Gene discovery may yield lettuce that will sprout in hot weather
7. UGA discovery may allow scientists to make fuel from CO2 in the atmosphere
8. Discovery could increase efficacy of promising cystic fibrosis drug
9. Discovery of first motor with revolution motion in a virus-killing bacteria advances nanotechnology
10. Discovery could yield treatment for cocaine addicts
11. Discovery may explain how prion diseases spread between different types of animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... MARC (Maximizing Access to Research Careers) Program has announced ... Human Genetics from October 18 22, 2014 in ... promote the entry of students, post doctorates and scientists ... science community and to encourage the participation of young ... This year MARC conferred 16 awards totaling $29,600., The ...
(Date:8/28/2014)... to Research Careers) Program has announced the travel ... 27th Annual Mouse Molecular Genetics Conference from September ... California. These awards are meant to promote ... from underrepresented groups into the mainstream of the ... of young scientists at the Genetics Society of ...
(Date:8/28/2014)... Aug. 28, 2014  Privacy Advocate and Senior Staff ... Lynch , joins the lineup of biometric and mobile ... Biometrics UnPlugged Executive Summit in Tampa, Florida ... Previously announced speakers include Steven Rahman, Director, Technology and Strategy ... at Experian. The theme of this year,s event is ...
Breaking Biology News(10 mins):Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2
... damage, for example as a result of exposure to ionizing ... damage or program themselves for death, a process called apoptosis. ... as it is remarkable, involving what might be described metaphorically ... DNA packed tightly in the cell nucleus. In intricate ...
... prevalence of a certain form of drug-resistant ... surpassed that of two other common antimicrobial-resistant ... a study conducted by researchers at Hebrew ... long-term care facilities are one of the ...
... offshore drilling last year, federal lawmakers have grappled with the ... allow oil, wave and wind energy development, while sustainably managing ... A new policy paper, published April 10 in Science ... establishing a public trust doctrine for federal waters could be ...
Cached Biology News:CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 2CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 3CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 4Study finds multidrug-resistant gram-negative bacteria high in long-term care 2Public trust doctrine could aid management of US oceans 2Public trust doctrine could aid management of US oceans 3
(Date:8/28/2014)... PARK, Calif. , Aug. 28, 2014 /PRNewswire/ ... focused on developing novel mid- to late-stage cardiovascular ... $7.0 million in its first round of financing. ... Biomedical Investments and Hercules Bioventures with participation from ... entrepreneur and pharmaceutical executive, Dr. Larry Hsu ...
(Date:8/28/2014)... MA (PRWEB) August 28, 2014 ... wholesale construction materials, selected SoundConnect to ... their cloud based audio and web conferencing platform ... to support PrimeSource’s employees’ needs. SoundConnect delivers ... , PrimeSource Building Products will be utilizing ...
(Date:8/27/2014)... Rhythm, a biopharmaceutical company developing peptide therapeutics ... in metabolic disorders, announced today that it has filed ... Securities and Exchange Commission (SEC) relating to the proposed ... The number of shares to be offered and the ... determined. Citigroup and Cowen and Company will ...
(Date:8/27/2014)... 2014 The Global and China Trifluoroacetic ... the current state of the Trifluoroacetic Acid industry in ... overview of the industry, including definitions, applications and industry ... analysis are provided with a focus on history, developments, ... between the international and Chinese situation is also offered. ...
Breaking Biology Technology:Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3PrimeSource Chooses SoundConnect as Collaboration Provider 2Rhythm Files Registration Statement for Proposed Initial Public Offering 2Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2
... ... an antibody designed to block signaling of ErbB3. This is the first of multiple trials ... 2 clinical development program for MM-121. , ... Cambridge, Mass. (PRWEB) February 22, 2010 -- Merrimack Pharmaceuticals, Inc. announced today that ...
... , ... ... , , , ... ...
... ... ... ... ...
Cached Biology Technology:Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-121 and Tarceva in Patients with Non-Small Cell Lung Cancer 2Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-121 and Tarceva in Patients with Non-Small Cell Lung Cancer 3BioCrossroads' Indiana Seed Fund Invests in Vaccine Biotech Company 2BioCrossroads' Indiana Seed Fund Invests in Vaccine Biotech Company 3BioCrossroads' Indiana Seed Fund Invests in Vaccine Biotech Company 4BioCrossroads' Indiana Seed Fund Invests in Vaccine Biotech Company 5BioCrossroads' Indiana Seed Fund Invests in Vaccine Biotech Company 6BioCrossroads' Indiana Seed Fund Invests in Vaccine Biotech Company 7Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California 2Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California 3Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California 4Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California 5
... of mouse embryonic stem cells to dopaminergic ... midbrain, where they are mainly located in ... and the retrorubral field. These dopaminergic (DA) ... innervation ( e.g.projections to the caudate nucleus, ...
... provides a comprehensive epitope analysis service ... on Paraflo microfluidic chips for immunological ... This comprehensive service includes assistance with ... sample(s) provided by you, single or ...
... ,Schistosomal glutathione-S-transferase (GST) is commonly used ... in E. coli (1). The GSTTag sequence ... and in some cases the solubility of ... soluble, properly folded form, GSTTag fusion proteins ...
... is commonly used as a fusion partner ... The GSTTag sequence has been reported to ... the solubility of its fusion partners. When ... GSTTag fusion proteins can be purified with ...
Biology Products: